Orthogon Therapeutics

Stub active Updated Apr 19, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location Canton, Massachusetts
Founded 2022
Latest Stage Follow-on
Total Raised $11M
Website https://www.orthogontx.com
Sector
biotech therapeutics antivirals

About

Orthogon Therapeutics is a Canton, Massachusetts-based biotech developing first-in-class oral antiviral drugs targeting BK polyomavirus infection in transplant patients 1.

Funding History

Date Round Amount Lead Co-investors
2026-04-17 Follow-on $11M — — 1

What Investors Say

No independently sourced investor quotes found.

What Founders Say

No independently sourced founder quotes found.

Sources

  1. BusinessWire, “Orthogon Therapeutics Raises an Additional $11M Financing for Its BK Virus Antiviral Drug Program,” April 17, 2026, accessed April 19, 2026. https://www.businesswire.com/news/home/20260417911548/en/Orthogon-Therapeutics-Raises-an-Additional-%2411M-Financing-for-Its-BK-Virus-Antiviral-Drug-Program↩↩